丙型肝炎病毒感染的临床试验
总计18082个结果
-
VA Office of Research and DevelopmentGlaxoSmithKline完全的
-
Astellas Pharma IncAstellas Pharma US, Inc.完全的
-
XTL Biopharmaceuticals未知
-
Merck Sharp & Dohme LLC完全的
-
Taoyuan General HospitalMerck Sharp & Dohme LLC完全的
-
ReiThera SrlUniversity of Oxford; Oxford University Hospitals NHS Trust; University Hospital Birmingham完全的
-
Gilead Sciences终止慢性丙型肝炎美国, 澳大利亚, 加拿大, 新西兰
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Erasmus Medical CenterPublic Health Service of Rotterdam-Rijnmond招聘中
-
Peter J. Ruane, M.D.Janssen Scientific Affairs, LLC完全的
-
University of Maryland, BaltimoreMerck Sharp & Dohme LLC; Cairo University撤销
-
Gilead Sciences完全的丙型肝炎病毒感染德国, 美国, 澳大利亚, 英国, 加拿大, 法国, 新西兰
-
AbbVie (prior sponsor, Abbott)完全的
-
Beth Israel Medical Center终止
-
Gilead Sciences终止
-
Gilead Sciences完全的艾滋病病毒 | 丙型肝炎病毒美国, 新西兰, 加拿大, 波多黎各
-
Institut de Recherche pour le DeveloppementMinistry of Health, Thailand完全的
-
Public Health Service of AmsterdamZonMw: The Netherlands Organisation for Health Research and Development; Amsterdam University... 和其他合作者招聘中
-
Kawin Technology Share-holding Co., Ltd.KawinGreen Biotech Co., Ltd.完全的
-
National Taiwan University Hospital招聘中
-
Foundation for Innovative New Diagnostics, SwitzerlandInstitute of Tropical Medicine, Belgium完全的
-
National Taiwan University HospitalHoffmann-La Roche未知
-
University of OxfordGlaxoSmithKline; ReiThera Srl完全的
-
Icahn School of Medicine at Mount SinaiCenters for Disease Control and Prevention; National Institute for Occupational Safety and Health...完全的
-
HepNet Study House, German LiverfoundationGilead Sciences; Hannover Medical School完全的